脂质体纳米颗粒作为一种药物输送系统,用于改善多发性骨髓瘤治疗
Nemany A N Hanafy1,2, Safacan Kolemen1,3
1Koç University Research Center for Translational Medicine (KUTTAM) 34450 Istanbul Turkiye skolemen@ku.edu.tr nhanafy@ku.edu.tr.
RSC advances
|March 16, 2026
概括
脂质体纳米疗法为治疗多发性骨髓瘤 (MM) 提供了一个有前途的方法,克服了传统化疗的局限性. 本综述强调了针对MM管理的向纳米颗粒的进展,并讨论了交付系统的挑战.
科学领域:
- 血液学 血液学 血液学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种具有挑战性的血液癌症.
- 传统的MM化疗药因副作用和耐药性而具有有限的疗效.
- 脂质体纳米疗法为克服这些局限性提供了一个新的策略.
研究的目的:
- 审查针对多发性骨髓瘤 (MM) 治疗的向脂肪体纳米颗粒的最新进展.
- 探索纳米疗法在解决现有治疗限制方面的潜力.
- 讨论开发MM有效药物输送系统的挑战.
主要方法:
- 在MM管理中针对性脂肪体纳米颗粒的文献综述.
- 分析药物输送系统当前面临的挑战.
- 探索向方法和可控的药物释放.
主要成果:
- 脂质体纳米疗法在MM治疗中显示出前景.
- 有针对性的纳米颗粒有可能克服化学阻力和副作用.
- 在有效的药物输送,向和受控释放方面仍然存在挑战.
结论:
- 向的脂质体纳米颗粒代表了MM治疗策略的重大进步.
- 需要进一步的研究来应对药物输送和临床应用的向方面的挑战.
- 纳米治疗药物有可能改善多发性骨髓瘤患者的治疗结果.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
71
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
71
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82